• OPEN AN ACCOUNT
Indian Indices
Sensex
76,515.43 362.57
( 0.48%)
Global Indices
Nasdaq
53,423.66 -283.45
(-0.53%)
Dow Jones
7,737.34 -31.37
(-0.40%)
Hang Seng
65,002.68 788.20
(1.23%)
Nikkei 225
10,828.70 -2.82
(-0.03%)
Forex
USD-INR
94.48 -0.24
(-0.26%)
EUR-INR
109.71 0.00
(0.00%)
GBP-INR
127.63 -0.19
(-0.15%)
JPY-INR
0.60 0.01
(1.60%)

EQUITY - MARKET SCREENER

Alembic Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
533573
INE901L01018
285.6722314
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
APLLTD
20.12
15878.37
EPS(TTM)
Face Value()
Div & Yield %
40.14
2
1.49
 

Rajkamal Synthetics standalone net profit declines 41.67% in the March 2026 quarter
May 30,2026
Net profit of Rajkamal Synthetics declined 41.67% to Rs 0.07 crore in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025. Sales declined 6.45% to Rs 1.16 crore in the quarter ended March 2026 as against Rs 1.24 crore during the previous quarter ended March 2025.

For the full year,net profit rose 18.18% to Rs 0.26 crore in the year ended March 2026 as against Rs 0.22 crore during the previous year ended March 2025. Sales rose 174.88% to Rs 5.69 crore in the year ended March 2026 as against Rs 2.07 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1.161.24 -6 5.692.07 175
OPM %6.0315.32 -6.6814.49 -
PBDT0.100.17 -41 0.410.28 46
PBT0.080.17 -53 0.330.27 22
NP0.070.12 -42 0.260.22 18